ATC code none PubChem CID 104974 ChemSpider 94726 Molar mass 552.5345 g/mol | CAS Number 142001-63-6 IUPHAR/BPS 2111 ChEMBL CHEMBL308148 | |
 | ||
How to pronounce saredutant
Saredutant (SR-48,968) is a drug that acts as a NK2 receptor antagonist. It was under development by Sanofi-Aventis as a novel antidepressant and anxiolytic and made it to phase III clinical trials. However, in May 2009, Sanofi-Aventis published its quarterly results and announced the cessation of 14 research/development projects, among which was saredutant for the treatment of major depressive disorder.
References
Saredutant Wikipedia(Text) CC BY-SA